Table 4.
Parameter | DA-8159 | Parameter | Metformin | ||
---|---|---|---|---|---|
Without metformin | With metformin | Without DA-8159 | With DA-8159 | ||
Disappearance of DA-8159 | Disappearance of metformin | ||||
Vmax (nmol min–1 mg protein–1) | 81.6±24.9 | 96.1±21.9 | Vmax (nmol min–1 mg protein–1) | 107±43.5 | 134±36.9 |
Km (μM) | 0.166±0.0252 | 0.226±0.0940 | Km (μM) | 0.284±0.101 | 0.347±0.159 |
CLint (μl min–1 mg protein–1) | 2.14±0.565 | 2.30±0.527 | CLint (μl min–1 mg protein–1) | 2.84±1.11 | 2.59±1.01 |
Ki (μM) for the inhibition of metabolism of metformin | 11.2–32.6 | Ki (μM) for the inhibition of metabolism of DA-8159 (formation of DA-8164) | 50.2–86.2 (11.0–35.9) | ||
[I]/Ki for the inhibition of metabolism of metformin | 0.199–0.346 | [I]/Ki for the inhibition of metabolism of DA-8159 (formation of DA-8164) | 0.0700–0.120 (0.168–0.548) | ||
Formation of DA-8164 | |||||
Vmax (nmol min–1 mg protein–1) | 52.0±26.1 | 46.6±11.1 | |||
Km (μM) | 0.0550±0.0160 | 0.0693±0.0187 | |||
CLint (μl min–1 mg protein–1) | 1.19±0.364 | 1.54±0.562 |
Data are expressed as mean±s.d. (DA-8159 without metformin, DA-8159 with metformin, n=4; metformin without and with DA-8159, n=5).